TTR and Alzheimer disease: If the soluble Aβ oligomers or fibrils are the neuro-toxic elements in AD patients or mouse models, the protective property of TTR can be a simple function of inhibiting aggregation and fibril formation by binding Aβ aggregates thus reducing their toxicity, as has been shown in vitro.